CD4/CD8 ratio during natalizumab treatment in multiple sclerosis patients.
published in: Journal of Neuroimmunology
date of publication: 2017-05-12
Cites articles
There is nothing here
Article - wd:Q50950889
There is nothing here
Article - wd:Q50950889